Skip to content

Qi-blood related theories Basing on the combination of syndrome and symptom

Qi stagnation and blood stasis (QSBS) and qi deficiency and blood stasis (QDBS) (same disease certificate) of clinical research

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR1900002800
Enrollment
Unknown
Registered
2019-12-03
Start date
2019-12-05
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Qi stagnation and blood stasis (QSBS) and qi deficiency and blood stasis (QDBS) in coronary heart disease

Interventions

Sponsors

Beijing Anzhen Hospital, Capital Medical University; Beijing Institute of Heart, Lung and Blood Vessel Diseases
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) To meet the diagnostic criteria of acute coronary syndromes, and within 48 hours, the coronary interventional operation was proposed; (2) TCM syndrome differentiation is qi stagnation blood stasis syndrome or qi deficiency and blood stasis; (3) Between the ages of 35 and 75; (4) Sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Renal insufficiency, male serum creatinine >0 2.5 mg/dl (>220umo/l) female >2.0 mg/dl(> 175 umo/l); (2) Patients with obvious liver disease or ALT and AST were three times higher than normal; (3) Severe cardiac dysfunction (EF= 13.7mmol/L in diabetic patients or glycosylated hemoglobin >= 9.5%; (5) Serious mental illness; (6) A malignant tumor or a patient has a life expectancy of less than 3 years; (7) Serious hematopoietic disease patients; (8) Refusal to sign the informed consent, or to estimate the poor compliance and follow-up possibility; (9) Pregnancy or preparation of pregnant women, lactating women; (10) Have participated in or are participating in other clinical trials in the past three months.

Design outcomes

Primary

MeasureTime frame
Cyclic miRNA;Echocardiography;Serum metabonomics;Vasoactive substance;Coronary artery angiography;Inflammatory mediators;energy metabolism;Five items of coagulation;

Secondary

MeasureTime frame
blood fat;electrocardiogram;stool routine examination;brain natriuretic peptide;renal function;Urine routine;troponin;Routine blood test;liver function;

Countries

China

Contacts

Public ContactJinghua Liu
lyp6314@sina.com+86 13811647832

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026